Multiple sclerosis in adults: management
Ano de publicação: 2022
This guideline covers diagnosing and managing multiple sclerosis in people aged 18 and over. It aims to improve the quality of life for people with multiple sclerosis by promoting prompt and effective symptom management and relapse treatment, and comprehensive reviews.
NICE has also produced technology appraisal guidance on disease-modifying treatments for multiple sclerosis, listed on NICE’s webpage on multiple sclerosis.
Multiple Sclerosis/therapy, Multiple Sclerosis/diagnosis, Ataxia/therapy, Selective Serotonin Reuptake Inhibitors/therapeutic use, Fatigue/therapy, Multiple Sclerosis/rehabilitation, Fatigue/drug therapy, Mobility Limitation, Muscle Spasticity/drug therapy, Dystonia/drug therapy, Tremor/drug therapy